Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

norgestrel

A synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes. This agent also exhibits antiproliferative activity in endometrial tissue and may exhibit chemopreventive and antineoplastic activities in endometrial carcinoma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Neogest
Ovrette
Code name:Wy-3707
Chemical structure:(+/-)-13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yne-3-one
(17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search